Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOTUM | Q6P988 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | GABRA2 | P47869 | 5/20 | 0.40 |
| ▸ | GABRB2 | P47870 | 5/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | GLA | P06280 | 1/20 | 0.39 |
| ▸ | GABRP | O00591 | 1/20 | 0.39 |
| ▸ | GABRD | O14764 | 1/20 | 0.39 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.39 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5591480 | 0.79 | NOTUM (0.52) | NOTUMCYP1A2ALDH1A1KDM4EHPGD | |
| SCHEMBL25153647 | 0.78 | NOTUM (0.51) | NOTUMCYP1A2ALDH1A1KDM4EHPGD | |
| SCHEMBL12458255 | 0.75 | NOTUM (0.49) | NOTUMCYP1A2ALDH1A1KDM4EHPGD | |
| SCHEMBL28934829 | 0.75 | NOTUM (0.49) | NOTUMCYP1A2ALDH1A1KDM4EHPGD | |
| SCHEMBL16268515 | 0.75 | NOTUM (0.49) | NOTUMCYP1A2ALDH1A1KDM4EHPGD | |
| SCHEMBL25868326 | 0.75 | NOTUM (0.49) | NOTUMCYP1A2ALDH1A1KDM4EHPGD | |
| SCHEMBL14151307 | 0.74 | NOTUM (0.48) | NOTUMCYP1A2ALDH1A1KDM4EHPGD | |
| SCHEMBL28934757 | 0.74 | NOTUM (0.48) | NOTUMCYP1A2ALDH1A1KDM4EHPGD | |
| SCHEMBL24036185 | 0.74 | NOTUM (0.48) | NOTUMCYP1A2ALDH1A1KDM4EHPGD | |
| SCHEMBL15148626 | 0.73 | NOTUM (0.47) | NOTUMCYP1A2ALDH1A1KDM4EHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7491818-B2 | Nucleic acid labeling compounds | AFFYMETRIX, INC. (US) | 2009-02-17 | — | — | US | disclosed |
| US-7423143-B2 | Nucleic acid labeling compounds | AFFYMETRIX. INC. (US) | 2008-09-09 | — | — | US | disclosed |
| US-7291463-B2 | Incubating/condensating pseudoisocytidine molecule with (1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride to provide a pseudouridine molecule; oncology diagnosis | AFFYMETRIX, INC. (US) | 2007-11-06 | — | — | US | disclosed |
| US-7282327-B2 | Nucleic acid labeling compounds | AFFYMETRIX, INC. (US) | 2007-10-16 | — | — | US | disclosed |
| US-7179905-B2 | Nucleic acid labeling compounds | AFFYMETRIX, INC. (US) | 2007-02-20 | — | — | US | disclosed |
| US-20050287563-A1 | Nucleic acid labeling compounds | AFFYMETRIX, INC. | 2005-12-29 | — | — | US | disclosed |
| US-6965020-B2 | Nucleic acid labeling compounds | AFFYMETRIX, INC. (US) | 2005-11-15 | — | — | US | disclosed |
| EP-1589025-A2 | Nucleic acid labeling compounds | Affymetrix, Inc. (US) | 2005-10-26 | — | — | EP | disclosed |
| US-20050164268-A1 | Nucleic acid labeling compounds | AFFYMETRIX, INC. | 2005-07-28 | — | — | US | disclosed |
| EP-1124838-B1 | NUCLEIC ACID LABELING COMPOUNDS | AFFYMETRIX INC (US) | 2005-06-01 | — | — | EP | disclosed |
| US-20040002595-A1 | Nucleic acid labeling compounds | AFFYMETRIX, INC. | 2004-01-01 | — | — | US | disclosed |
| US-20030232979-A1 | Nucleic acid labeling compounds | AFFYMETRIX, INC. | 2003-12-18 | — | — | US | disclosed |
| US-20030180757-A1 | Nucleic acid labeling compounds | AFFYMETRIX, INC. | 2003-09-25 | — | — | US | disclosed |
| US-6596856-B2 | For probes, comprising a heterocycle condensed with a cyclic group such as ribofuranose derivative; biotin and 5-carboxyfluorescein derivatives | AFFYMETRIX, INC. | 2003-07-22 | — | — | US | disclosed |
| US-20020165372-A1 | Nucleic acid labeling compounds | AFFYMETRIX, INC. | 2002-11-07 | — | — | US | disclosed |
| WO-2000006771-A9 | NUCLEIC ACID LABELING COMPOUNDS | AFFYMETRIX INC (US) | 2002-08-22 | — | — | WO | disclosed |
| US-20010044531-A1 | Nucleic acid labeling compounds | AFFYMETRIX, INC. | 2001-11-22 | — | — | US | disclosed |
| US-20010018514-A1 | NUCLEIC ACID LABELING COMPOUNDS | AFFYMETRIX, INC. | 2001-08-30 | — | — | US | disclosed |
| EP-1124838-A2 | NUCLEIC ACID LABELING COMPOUNDS | Affymetrix, Inc. (US) | 2001-08-22 | — | — | EP | disclosed |
| WO-2000006771-A2 | NUCLEIC ACID LABELING COMPOUNDS | AFFYMETRIX, INC. (US) | 2000-02-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040002595-A1 | Nucleic acid labeling compounds | RNGTT, DUT, FBL | NOTUM 2632/4885CYP1A2 3633/4885ALDH1A1 760/4885 |
| US-20030180757-A1 | Nucleic acid labeling compounds | RNGTT, DUT, FBL | NOTUM 2632/4885CYP1A2 3633/4885ALDH1A1 760/4885 |
| US-20050164268-A1 | Nucleic acid labeling compounds | RNGTT, DUT, FBL | NOTUM 2632/4885CYP1A2 3633/4885ALDH1A1 760/4885 |
| US-20010044531-A1 | Nucleic acid labeling compounds | RNGTT, DUT, FBL | NOTUM 2632/4885CYP1A2 3633/4885ALDH1A1 760/4885 |
| US-20050287563-A1 | Nucleic acid labeling compounds | RNGTT, DUT, FBL | NOTUM 2632/4885CYP1A2 3633/4885ALDH1A1 760/4885 |
| US-20010018514-A1 | NUCLEIC ACID LABELING COMPOUNDS | RNGTT, DUT, FBL | NOTUM 2632/4885CYP1A2 3633/4885ALDH1A1 760/4885 |
| US-20020165372-A1 | Nucleic acid labeling compounds | RNGTT, DUT, FBL | NOTUM 2632/4885CYP1A2 3633/4885ALDH1A1 760/4885 |
| US-20030232979-A1 | Nucleic acid labeling compounds | RNGTT, DUT, FBL | NOTUM 2632/4885CYP1A2 3633/4885ALDH1A1 760/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.